Open: US FDA’s Docket For NAC Comments, And CRN On Its Options To Contest Enforcement

Docket remained closed for a few days after FDA asked for additional comments on whether to conduct NAC rulemaking. FDA, says CRN, turned DSHEA on its head in 2020 when it said NAC was approved as a drug and couldn’t be used as a dietary ingredient.